NDC 50090-6115-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6115
- Requested NDC
- 50090-6115-01
- Package NDCs from labels
- 50090-6115-0, 50090-6115-1, 50090-6115-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2026-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6115-0 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 8 | |
| 50090-6115-1 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6115 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 5 | Current NDC, Legacy NDC, 2 package rows | 20230723_008de8fd-150f-4022-8ccb-c8bfa94875c7.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6115-0 | EA - Each | 50090-6115 | cf44c25b-d14b-4086-b06a-a97689aececc | 1 | 2022-11-07 |
| 50090-6115-1 | EA - Each | 50090-6115 | 2e8779cc-3f4a-4c7c-9857-12ad18e3fab4 | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 853d9e86-2b5b-4967-8c22-70ad34f03418 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b42fe9dd-8383-4839-9eab-393de388da71 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fa7dd488-de7e-4f9e-87db-18391b723aad | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966270 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 394b1006-c160-4668-8684-82d1c4481202 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 8e11401b-f5c2-42ac-ba63-2e71b5626b7e | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Aflora | MULTIVITAMIN | Oncora Pharma, LLC | 38e463d1-f608-7cb5-e063-6294a90a4abb | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Folixia | MULTIVITAMIN | Oncora Pharma, LLC | 413945b5-116b-d8b6-e063-6394a90a55e8 | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Nutralyn | MULTIVITAMIN | Oncora Pharma, LLC | 33da017b-1e8c-d41c-e063-6394a90aab8c | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Folaten | MULTIVITAMIN | Oncora Pharma, LLC | 93086235-2c33-424d-b0c3-213031988581 | 2026-02-12 | Warnings, Adverse reactions | 3A3U0GI71G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4520fae0-acce-47a0-af9e-f4f16ea6b268 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2ce47caf-6ece-429c-b5d7-c47ba6952800 | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 99df68ea-4de7-4825-a6d7-894c70d01c28 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 4f26f9dc-cf49-4b55-a6f7-f2f579893ee4 | 2026-02-10 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2b737395-0238-400b-95ff-890b95c98425 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | ASCLEMED USA INC. | 42a26f8a-dc67-42e4-abb0-d2602afb1b7d | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 1ac29774-2b53-4a3f-97fa-16c2880a0868 | 2026-02-06 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b717aff6-f754-458d-be87-d12d87c5da00 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 62de26a8-d6fc-463f-abe6-4656228c3142 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Northwind Health Company, LLC | ffc34bc6-5de5-addb-e053-6294a90a25be | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 49136b34-1bc1-ec4e-e063-6394a90ac9dd | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.